Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

BIO Bio Rad Laboratories Inc

326,91

1,33 (0,41%)

Vor Marktöffnung

Zuletzt aktualisiert: 14:26:38

Verzögert um 15 Minuten

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

06/13/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Michael William Crowley

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Bio Rad Laboratories Charts.

Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Bio Rad Laboratories Charts.

News Bio Rad Laboratories Inc

Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference
Donnerstag 21 November 2024 (1 Tag vor) • Business Wire

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
Donnerstag 31 Oktober 2024 (3 Wochen vor) • Business Wire

Bio-Rad Reports Third-Quarter 2024 Financial Results
Mittwoch 30 Oktober 2024 (3 Wochen vor) • Business Wire

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
Montag 14 Oktober 2024 (1 Monat vor) • Business Wire

Valerio Therapeutics Reports its Half-Year 2024 Financial Results and Provides an Update on its Activities
Montag 30 September 2024 (2 Monate vor) • Business Wire

Dell, Palantir, and Erie Will Be Added to the S&P 500; Boeing Avoids Strike; Apple Event Takes Place Today
Montag 9 September 2024 (2 Monate vor) • IH Market News

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
Samstag 7 September 2024 (3 Monate vor) • PR Newswire (US)

Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference
Donnerstag 22 August 2024 (3 Monate vor) • Business Wire

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
Dienstag 20 August 2024 (3 Monate vor) • Business Wire

Bio-Rad Reports Second-Quarter 2024 Financial Results
Donnerstag 1 August 2024 (4 Monate vor) • Business Wire

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024
Mittwoch 17 Juli 2024 (4 Monate vor) • Business Wire

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 18 Juni 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere Bio Rad Laboratories Inc News-Artikel

Deutsche Telekom (QX)

JP Morgan Chase

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen